Literature DB >> 769883

Brain concentrations of biogenic amine metabolites in acutely treated and ethanol-dependent rats.

F Karoum, R J Wyatt, E Majchrowicz.   

Abstract

1 Mass fragmentography was used to measure whole brain concentrations of some of the major metabolites of tyramine, octopamine, dopamine and noradrenaline in acutely treated and in ethanol-dependent rats. 2 Treatments with ethanol, either acutely or chronically, failed to alter significantly brain concentration of p-hydroxphenylacetic and p-hydroxymandelic acid (metabolites derived from tyramine and octopamine respectively). The effect on catecholamine metabolites was marked and therefore suggests that ethanol is selective in its effect on central metabolism of biogenic amines. 3 Acute ethanol treatment significantly increased brain concentration of homovanillic acid (HVA), 3,4-dihydroxyphenylacetic acid (DOPAC) and 3-methoxy-4-hydroxyphenylglycol (MHPG). Vanilmandelic acid (VMA) was not affected. All four metabolites (HVA, DOPAC, MHPG and VMA) were increased in the brains of rats rendered dependent on ethanol while still intoxicated (blood ethanol levels above 200 mg/dl). In ethanol-dependent rats undergoing ethanol withdrawal syndrome (no ethanol present in blood), the brain concentrations of HVA and DOPAC were normal while those of MHPG and VMA continued to be elevated. 4 From the decline in the concentrations of HVA and DOPAC after 50 mg pargyline/kg in control rats and rats acutely treated with ethanol, it was concluded that ethanol has no effect on the transport of phenolic acids across the blood brain barrier. 5 No reversal in the metabolism of catecholamines from an oxidative to a reductive pathway, analogous to that produced by ethanol in the periphery, could be established in the brain. 6 The increase in catecholamine metabolite concentrations after ethanol treatment, either acute or chronic, were interpreted as manifestations of increases catecholamine turnover.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 769883      PMCID: PMC1666896          DOI: 10.1111/j.1476-5381.1976.tb07450.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  45 in total

1.  [INFLUENCE OF ALCOHOL ON THE MONOAMINES CONTENT OF THE CENTRAL NERVOUS SYSTEM].

Authors:  N RUDAS; L VACCA
Journal:  Acta Neurol (Napoli)       Date:  1964 Nov-Dec

2.  Uptake of 5-hydroxytryptophan-3-C-14 and its metabolism in rat brain cortex slices.

Authors:  J P VON WARTBURG
Journal:  Can J Biochem Physiol       Date:  1962-10

3.  The presence and distribution of tyramine in mammalian tissues.

Authors:  S SPECTOR; K MELMON; W LOVENBERG; A SJOERDSMA
Journal:  J Pharmacol Exp Ther       Date:  1963-05       Impact factor: 4.030

4.  Urinary excretion of 5-HIAA in chronic alcoholism.

Authors:  G E MURPHY; S B GUZE; L J KING
Journal:  JAMA       Date:  1962-11-03       Impact factor: 56.272

5.  In effectiveness of ethanol on noradrenaline, dopamine or 5-hydroxytryptamine levels in brain.

Authors:  J HAGGENDAL; M LINDQVIST
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1961

6.  Depression of serotonin and norepinephrine levels in brain stem of rabbit by ethanol.

Authors:  D GURSEY; R E OLSON
Journal:  Proc Soc Exp Biol Med       Date:  1960-06

7.  Evidence for a defect in tryptophan metabolism in chronic alcoholism.

Authors:  R E OLSON; D GURSEY; J W VESTER
Journal:  N Engl J Med       Date:  1960-12-08       Impact factor: 91.245

8.  Inhibitory influence of ethanol on serotonin metabolism.

Authors:  G ROSENFELD
Journal:  Proc Soc Exp Biol Med       Date:  1960-01

9.  The phenolic acids of human urine; paper chromatography of phenolic acids.

Authors:  M D ARMSTRONG; K N SHAW; P E WALL
Journal:  J Biol Chem       Date:  1956-01       Impact factor: 5.157

10.  The fate of parahydroxyphenylethylamine in the organism.

Authors:  A J Ewins; P P Laidlaw
Journal:  J Physiol       Date:  1910-10-11       Impact factor: 5.182

View more
  16 in total

1.  Noradrenaline receptor sensitivity after chronic ethanol administration.

Authors:  S Liljequist; N E Andén; J Engel; M Henning
Journal:  J Neural Transm       Date:  1978       Impact factor: 3.575

2.  Contributions of hippocampus and neocortex to the expression of ethanol effects.

Authors:  L D Devenport; R L Hale
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

Review 3.  Drug Addiction: Hyperkatifeia/Negative Reinforcement as a Framework for Medications Development.

Authors:  George F Koob
Journal:  Pharmacol Rev       Date:  2021-01       Impact factor: 25.468

4.  Ethanol-associated behaviors of mice lacking norepinephrine.

Authors:  D Weinshenker; N C Rust; N S Miller; R D Palmiter
Journal:  J Neurosci       Date:  2000-05-01       Impact factor: 6.167

5.  The effect of catecholamine receptor antagonists on ethanol-induced locomotor stimulation.

Authors:  S Liljequist; U Berggren; J Engel
Journal:  J Neural Transm       Date:  1981       Impact factor: 3.575

6.  Effects of GABAergic agonists and antagonists on various ethanol-induced behavioral changes.

Authors:  S Liljequist; J Engel
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

7.  Acute and chronic ethanol administration on specific 3H-GABA binding in different rat brain areas.

Authors:  A Reggiani; M L Barbaccia; P F Spano; M Trabucchi
Journal:  Psychopharmacology (Berl)       Date:  1980       Impact factor: 4.530

8.  Central Noradrenergic Interactions with Alcohol and Regulation of Alcohol-Related Behaviors.

Authors:  Elena M Vazey; Carolina R den Hartog; David E Moorman
Journal:  Handb Exp Pharmacol       Date:  2018

9.  Noradrenergic response to acute ethanol administration in healthy subjects: comparison with intravenous yohimbine.

Authors:  C J McDougle; J H Krystal; L H Price; G R Heninger; D S Charney
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

10.  Reversal of ethanol intoxication in humans: an assessment of the efficacy of L-dopa, aminophylline, and ephedrine.

Authors:  R L Alkana; E S Parker; H B Cohen; H Birch; E P Noble
Journal:  Psychopharmacology (Berl)       Date:  1977-12-28       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.